What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His primary scientific interests are in Internal medicine, Surgery, Thrombosis, Intensive care medicine and Anticoagulant.
Much of his study explores Internal medicine relationship to Cardiology.
His research integrates issues of Incidence, Cohort study and Vitamin K antagonist in his study of Surgery.
His Thrombosis research includes elements of Hemostasis, Pulmonary embolism, First episode and Hazard ratio.
His Intensive care medicine study incorporates themes from Dabigatran, Disease and Antithrombotic.
Walter Ageno has included themes like Rivaroxaban, Warfarin and Randomized controlled trial in his Anticoagulant study.
His most cited work include:
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (1132 citations)
- Oral Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (1058 citations)
- Cardiovascular Risk Factors and Venous Thromboembolism. A Meta-Analysis (652 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Thrombosis, Surgery, Intensive care medicine and Pulmonary embolism.
His Cardiology research extends to Internal medicine, which is thematically connected.
His study explores the link between Thrombosis and topics such as Anticoagulant that cross with problems in Randomized controlled trial.
His Surgery research is multidisciplinary, incorporating perspectives in Incidence, Cohort study and Warfarin.
Walter Ageno has researched Intensive care medicine in several fields, including Rivaroxaban, Clinical trial, Antithrombotic, Heparin and Disease.
His Confidence interval research is multidisciplinary, relying on both Odds ratio and Meta-analysis.
He most often published in these fields:
- Internal medicine (52.39%)
- Thrombosis (33.10%)
- Surgery (31.33%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (52.39%)
- Thrombosis (33.10%)
- Pulmonary embolism (22.83%)
In recent papers he was focusing on the following fields of study:
Walter Ageno spends much of his time researching Internal medicine, Thrombosis, Pulmonary embolism, Randomized controlled trial and Venous thromboembolism.
His Confidence interval, Hazard ratio, Anticoagulant, Incidence and Cancer investigations are all subjects of Internal medicine research.
His Thrombosis study combines topics in areas such as Emergency department, Retrospective cohort study and Intensive care medicine.
His study in Pulmonary embolism is interdisciplinary in nature, drawing from both Cause of death, Prospective cohort study, Cohort study and Subgroup analysis.
His Randomized controlled trial research integrates issues from Meta-analysis, Propensity score matching and Heparin.
His research in Venous thromboembolism focuses on subjects like Vitamin K antagonist, which are connected to Cohort, Hematology and Clinical trial.
Between 2019 and 2021, his most popular works were:
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (1132 citations)
- Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. (178 citations)
- COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET). (123 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
Internal medicine, Confidence interval, Randomized controlled trial, Pulmonary embolism and Incidence are his primary areas of study.
As part of his studies on Internal medicine, Walter Ageno often connects relevant areas like Placebo.
His studies in Pulmonary embolism integrate themes in fields like Asymptomatic and Deep vein.
His Deep vein research is within the category of Thrombosis.
The study incorporates disciplines such as Cancer and Splanchnic vein thrombosis in addition to Incidence.
His Hazard ratio research is multidisciplinary, incorporating perspectives in Anticoagulant and Stroke.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
